Exodus Point Capital Management, LP Viracta Therapeutics, Inc. Transaction History

Exodus Point Capital Management, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 19, 2022	SELL	$1.87 - $5.0 $54,132 - $144,740	-28,948 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$2.23 - $4.76 $64,554 - $137,792	28,948 New	28,948 $138,000
Q2 2021 Aug 16, 2021	SELL	$7.55 - $12.95 $456,344 - $782,736	-60,443 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$7.58 - $18.67 $458,157 - $1.13 Million	60,443 New	60,443 $559,000

5.63M

Ticker VIRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,558,200
Market Cap $9.39M
Description
Viracta Therapeutics, Inc., a precision oncology company, engages in developing drugs for the treatment of virus-associated malignancies. Its lead product candidature includes Nana-val, in combination with nanatinostat and valganciclovir that is in Phase II clinical trial for Epstein-Barr virus-positive lymphoma; and open-label Phase 2 basket tr...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.